Human cytomegalovirus DNA and immediate early protein 1/2 are highly associated with glioma and prognosis

References

[1] Cheng S, Jiang X, Yang B, Wen L, Zhao F, Zeng WB, Liu XJ, Dong X, Sun JY, Ming YZ (2017) Infected T98G glioblastoma cells support human cytomegalovirus reactivation from latency. Virology 510:205–215

[2] Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG,Britt WJ (2002) Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62:3347–3350

[3] Cobbs CS, Soroceanu L, Denham S, Zhang WY, Kraus MH(2008) Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity. Cancer Res 68:724–730

[4] Ding DL, Han S, Wang ZX, Guo ZZ, Wu AH (2014) Does the existence of HCMV components predict poor prognosis in glioma? J Neuro-Oncol 116:515–522

[5] Dziurzynski K,Chang SM, Heimberger AB, Kalejta RF, McGregor Dallas SR, Smit M, Soroceanu L,Cobbs CS, HCMV and Gliomas Symposium (2012) Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol 14:246–255

[6] Fornara O, Bartek J, Rahbar A, Odeberg J, Khan Z, Peredo I, Hamerlik P, Bartek J, Stragliotto G, Landazuri N (2016) Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact. Cell Death Differ 23:261–269

[7] Gurrieri C, Capodieci P, Bernardi R, Scaglioni PP, Nafa K, Rush LJ, Verbel DA, Cordon-Cardo C, Pandolfi PP (2004) Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J Natl Cancer Inst 96:269–279

[8] Krenzlin H, Behera P, Lorenz V,Passaro C, Zdioruk M, Nowicki MO, Grauwet K,Zhang H, Skubal M, Ito H (2019) Cytomegalovirus promotes murine glioblastoma growth via pericyte recruitment and angiogenesis. J Clin Invest 129:1671–1683

[9] Kumar A, Tripathy MK, Pasquereau S, Al Moussawi F, Abbas W, Coquard L, Khan KA, Russo L, Algros MP, Valmary-Degano S (2018) The human cytomegalovirus strain db activates oncogenic pathways in mammary epithelial cells. EBioMedicine 30:167–183

[10] Oberstein A, Shenk T (2017) Cellular responses to human cytomegalovirus infection: Induction of a mesenchymal-to-epithelial transition (MET) phenotype. Proc Natl Acad Sci USA 114: E8244–E8253

[11] Soderberg-Naucler C, Rahbar A, Stragliotto G(2013) Survival in patients with glioblastoma receiving valganciclovir. N Engl J Med 369:985–986

[12] Tang KW, Hellstrand K, Larsson E (2015) Absence of cytomegalovirus in high-coverage DNA sequencing of human glioblastoma multiforme. Int J Cancer 136:977–981

[13] Tarrant-Elorza M, Rossetto CC, Pari GS (2014) Maintenance and replication of the human cytomegalovirus genome during latency. Cell Host Microbe 16:43–54

[14] Yamashita Y, Ito Y, Isomura H, Takemura N, Okamoto A, Motomura K, Tsujiuchi T, Natsume A, Wakabayashi T, Toyokuni S (2014) Lack of presence of the human cytomegalovirus in human glioblastoma. Mod Pathol 27:922–929

[15] Young LS, Yap LF, Murray PG (2016) Epstein-Barr virus: more than 50 years old and still providing surprises. Nat Rev Cancer 16:789–802

RIGHTS & PERMISSIONS

The Author(s)